FTD: Clinical Trials

2 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Terminated 2
Phase 2	2	Terminated 2

Follow FTD: new trials by email Literature Review of FTD trials Research Report on FTD

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes PBFT02 - Frontotemporal Dementia, FTD	Phase 1 / Phase 2	Terminated	Passage Bio, Inc.	30	2021-09-14	2026-10-29
Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) WVE-004, Placebo - ALS, FTD	Phase 1 / Phase 2	Terminated	Wave Life Sciences USA, Inc.	35	2021-06-28	2023-10-23

Narrower conditions

Frontotemporal Dementia (1)  ·  Frontotemporal Dementia With Motor Neuron Disease (1)  ·  Pick Disease of the Brain (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Frontotemporal Lobar Degeneration (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Proteostasis Deficiencies (1)  ·  TDP-43 Proteinopathies (1)

Sponsors

Passage Bio, Inc. (1)  ·  Wave Life Sciences USA, Inc. (1)

Countries

Australia (2)  ·  Canada (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Portugal (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)